We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Tools for Meningitis Diagnostics Implemented in Resource-Limited Settings

By LabMedica International staff writers
Posted on 14 Jan 2019
Meningitis remains a top cause of premature death and loss of disability-adjusted life years in low-income countries. More...
In resource-limited settings, proper laboratory diagnostics are often scarce and knowledge about national and local epidemiology is limited.

Misdiagnosis, incorrect treatment and overuse of antibiotics are potential consequences, especially for viral meningitis. Early treatment is essential in the clinical management of meningitis. A delay in therapy negatively affects the prognosis for patients with both bacterial and viral meningitis/encephalitis.

Scientists from the University of Oslo (Oslo, Norway) and their Ethiopian colleagues conducted a prospective study over three months in a teaching hospital in Ethiopia. Cerebrospinal fluid (CSF) samples were collected from patients with suspected meningitis. Basic routine testing with microscopy and culture were performed and clinical data, as well as information on treatment and outcome were collected.

CSF samples were cultured onto blood agar and/or chocolate agar for 72 hours at 35 °C in a CO2-enriched incubator (candle jar). Routine bacterial identification was based on colony morphology, Gram staining and standard biochemical reactions. All CSF samples included in the study were analyzed using the meningitis/encephalitis (ME) panel on the bioMérieux FilmArray multiplex polymerase chain reaction system (PCR) system. Two hundred and eighteen patients were included; 117 (54%) neonates (0–29 days), 63 (29%) pediatrics (1 month-15 years) and 38 (17%) adults (≥16 years).

The investigators reported that of 218 CSF samples, 21 (10%) were PCR positive; 4% in neonates, 14% in pediatrics and 18% in adults. Virus was detected in 57% of the PCR positive samples, bacteria in 33% and fungi in 10%. All CSF samples that were PCR positive for a bacterial agent had a white cell count ≥75 cells/mm3 and/or turbid appearance. Only four (2%) of the CSF samples included in the study were found to be positive for microorganisms using conventional methods (microscopy and/or culture).

The authors concluded that a rapid molecular diagnostic system was successfully implemented in an Ethiopian setting without previous experience of molecular diagnostics. Viral meningitis was diagnosed for the first time in routine clinical practice in Ethiopia, and viral agents were the most commonly detected microorganisms in CSF. This study illustrates the potential of rapid diagnostic tests for reducing antibiotic usage in suspected meningitis cases. The study was published on December 20, 2018, in the journal BMC Infectious Diseases.

Related Links:
University of Oslo


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.